Geron

GERN73

High Growth

$3.66arrow_drop_down1.21%-$0.04

High Growth

Penny Stock

GERN73

$3.66

arrow_drop_down1.21%-$0.04

High Growth

Penny Stock

Performance History

Key Stats
Open	$3.73
Prev. Close	$3.71
EPS	-0.32
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$2.21B
PE Ratio	-

	LOW	HIGH
Day Range	3.63	3.77
52 Week Range	1.64	5.34

Ratios

Revenue	-



EBITDA Margin %	-

EPS	-0.32

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Geron (GERN)

Geron Corp (GERN) is a biopharmaceutical company that specializes in the development of innovative therapies for cancer treatments. With a market cap of $X billion, GERN has established itself as a key player in the industry. The company's focus lies in the research and development of therapies that target telomerase, an enzyme involved in the growth and survival of cancer cells. GERN's pioneering approach has gained significant attention and has the potential to revolutionize cancer treatment.

The company's stock price history shows fluctuations over the past few years. However, GERN has consistently demonstrated resilience and perseverance. Despite challenges, GERN has managed to maintain a stable position in the market. Investors trust GERN's potential and recognize the value it brings to the industry.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Dr. John A. Scarlett M.D.
Headquarters: Foster City
Employees: 107
Exchange: NASDAQ

Keep an eye on Geron

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is the 52-week high and low for Geron (GERN)?

For Geron (GERN), the 52-week high is $5.34, which is 45.9% from the current price. The 52-week low is $1.64, the current price is 123.17% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

What is Geron's (GERN) price per share?

The current price per share for Geron (GERN) is $3.66. The stock has seen a price change of -$0.04 recently, indicating a -1.21% change. This reflects the stock's recent market performance and investor sentiment.

help

Is Geron (GERN) a growth stock?

Geron (GERN) has shown an average price growth of -6.65% over the past three years. It has received a score of 86 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Geron as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Geron (GERN) stock price performance year to date (YTD)?

As of the latest data, Geron (GERN) has a year-to-date price change of 71.03%. Over the past month, the stock has experienced a price change of -12.23%. Over the last three months, the change has been -18.67%. Over the past six months, the figure is -6.15%. Looking at a longer horizon, the five-year price change stands at 188.19%.

help

Is Geron (GERN) a profitable company?

Geron (GERN) has a net income of -$184.13M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -99.8% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$193.94M. Furthermore, the EBITDA is -$207.45M.

help

What is the market capitalization of Geron (GERN)?

Geron (GERN) has a market capitalization of $2.21B. The average daily trading volume is 3.69, indicating the stock's liquidity and investor engagement.